AKT1 and breast cancer: Different hypotheses such as the activation of cell growth signaling pathways like the PIK3A/Akt/mTOR pathway, the overexpression of EGFR or the activation of the RAS-MEK-MAPK pathway have been the subject of research in breast cancer and have led to the development of specific treatments.